Edition:
United States

GenMark Diagnostics Inc (GNMK.OQ)

GNMK.OQ on NASDAQ Stock Exchange Global Market

4.24USD
15 Dec 2017
Change (% chg)

$-0.06 (-1.40%)
Prev Close
$4.30
Open
$4.29
Day's High
$4.42
Day's Low
$4.24
Volume
647,876
Avg. Vol
159,996
52-wk High
$13.67
52-wk Low
$3.63

Chart for

About

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $232.33
Shares Outstanding(Mil.): 54.80
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-Genmark Diagnostics Entered Fifth Amendment To Loan And Security Agreement

* GENMARK DIAGNOSTICS INC - ON DEC 13 CO ENTERED FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT WITH SOLAR SENIOR CAPITAL - SEC FILING

Dec 14 2017

BRIEF-Genmark Diagnostics Q3 loss per share $0.28

* Q3 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S

Nov 02 2017

CORRECTED-BRIEF-Genmark Diagnostics Q2 loss per share $0.37

* Q2 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S

Aug 01 2017

Earnings vs. Estimates